Author Archives: Masstortreport

First Taxotere Bellwether Trial Slated to Begin September 2019

Posted On: May 8, 2019 Posted In: Blog, Defective Drugs

The first bellwether trial in the Taxotere litigation has been scheduled for September 2019—just one of more than 12,000 liability lawsuits claiming that the chemotherapy drug’s manufacturer, Sanofi-Aventis, failed to adequately warn patients that permanent hair loss may result from taking the drug. U.S. District Judge Jane Triche Milazzo in the Eastern District of Louisiana . . Read More »

Bellwether Trials in Taxotere Lawsuit to Begin May 2019

Posted On: July 18, 2018 Posted In: Blog, Defective Drugs

On June 13th, the federal court overseeing thousands of Taxotere lawsuits ordered that bellwether trials will begin in May 2019. Taxotere (docetaxel) is a chemotherapy drug manufactured by Sanofi-Aventis. Recently, over 8,700 lawsuits have been filed alleging that alopecia (hair loss) caused by this drug is far more likely to be permanent compared to equally-effective alternative medications. . . Read More »